BioCatalystWatch
TCRXWorkspace / TCRX / OverviewCompany library
TScan Therapeutics, Inc. logo

TScan Therapeutics, Inc.

TScan Therapeutics, Inc. (TCRX)

Website

Price
Market cap
Next catalystDec 13, 2026TSC-101 — heme-program overview and continuing follow-up · Phase 1 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

TSC-102-A01

CD45

IND

PreINDP1P2P3FilingApproved
Upcoming / outlook

TSC-102-A03

CD45

IND

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

TSC-102-A03

CD45

IND

PreINDP1P2P3FilingApproved
Upcoming / outlook

TSC-102-A01

CD45

IND

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

TSC-203

Cell therapy

PRAME

PreINDP1P2P3FilingApproved
TSC-203

Cell therapy

PRAME

PreINDP1P2P3FilingApproved
TSC-302-A02

MAGE-A4

Upcoming / outlook

  • Timing and evidence

TSC-303-A02

PRAME

Upcoming / outlook

  • Timing and evidence

PRAME

PreINDP1P2P3FilingApproved
TSC-204-C0702

MAGE-A1

PreINDP1P2P3FilingApproved
TSC-204-A0201

MAGE-A1

PreINDP1P2P3FilingApproved

History / paused

HA-2

PreINDP1P2P3FilingApproved

Cell therapy

HA-1

PreINDP1P2P3FilingApproved

HA-2

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

TCRX PR & News

PR & News

TCRX SEC archive